Roche has agreed to a $5.3 billion deal with Zealand Pharma to develop the obesity drug candidate petrelintide, including a fixed-dose combination with Roche’s CT-388, aiming to compete in the weight loss drug market. Zealand Pharma will receive $1.65 billion upfront and potential milestone payments, with shares of both companies rising after the announcement. The partnership will see Roche and Zealand jointly commercialize petrelintide in the U.S. and Europe, sharing profits and losses equally, while Roche will have exclusive commercialization rights in the rest of the world.
Full Article
Petunia nabs the title in the “World’s Ugliest Dog Contest.” See photos of her fierce competitors
A dog named Petunia won the "World's Ugliest Dog Contest" at the Sonoma County Fair in Santa Rosa, California, earning $5,000 and recognition alongside her owner, Shannon Nyman. The nearly 50-year-old event promotes pet adoption and highlights the unique beauty of dogs, with many contestants being rescued from shelters. Want More Context? 🔎
Read more